Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05964348
Other study ID # CHUBX 2022/66
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date April 5, 2023
Est. completion date January 31, 2024

Study information

Verified date July 2023
Source University Hospital, Bordeaux
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this registry is to find and validate a correlation between morphological indicators such as volume sac evolution, graft migration or length between anatomical landmarks with aneurysm rupture risk or complications such as endoleaks requiring re-intervention… Secondary objectives are the validation of the reproducibility and accuracy of a dedicated fully automated software enabling Abdominal Aortic Aneurysm (AAA) segmentation to measure AAA diameter, volume evolution and growth over time, proximal and distal sealing zones analyze as well as device migration and integrity after EVAR on computed tomography angiography (CTA). This validation is in comparison with semi-automated analyse controlled by physician.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 31, 2024
Est. primary completion date August 31, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or female =18 years of age - Infra-renal Abdominal Aortic Aneurysm (AAA) treated with EVAR - =50mm - or =5mm increase in 6 months - or surviving Ruptured AAA - legal capacity to make own decisions, informed of the nature of the registry, has signed non opposition form available for set-up and proper implementation of follow-up visits throughout the duration of the registry Exclusion Criteria: - Advancing Alzheimer's disease or socially dependent patient - Opposition to the use of their data for this research - Life expectancy supposed to be inferior to 2 years Pregnant female

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
CT-Scan
semi-automated analyse by anatomical landmarks with a dedicated fully automated software

Locations

Country Name City State
France Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux Bordeaux cedex

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Bordeaux Nurea

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Collection of the different events and complications of the aneurysm post EVAR Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study Month 1
Primary Collection of the different events and complications of the aneurysm post EVAR Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study Month 3
Primary Collection of the different events and complications of the aneurysm post EVAR Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study Month 6
Primary Collection of the different events and complications of the aneurysm post EVAR Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study Month 12
Primary Measurement of aneurysm sac volume evolution Measurement of the aneurysm sac volume in cc on the CT scans available Month 1
Primary Measurement of aneurysm sac volume evolution Measurement of the aneurysm sac volume in cc on the CT scans available Month 3
Primary Measurement of aneurysm sac volume evolution Measurement of the aneurysm sac volume in cc on the CT scans available Month 6
Primary Measurement of aneurysm sac volume evolution Measurement of the aneurysm sac volume in cc on the CT scans available Month 12
Primary Measurement of morphological neck characteristics Measurement of the morphological neck characteristics in mm on the CT scans available Month 6 before intervention
Primary Measurement of morphological neck characteristics Measurement of the morphological neck characteristics in mm on the CT scans available Month 1
Primary Measurement of morphological neck characteristics Measurement of the morphological neck characteristics in mm on the CT scans available Month 3
Primary Measurement of morphological neck characteristics Measurement of the morphological neck characteristics in mm on the CT scans available Month 6
Primary Measurement of morphological neck characteristics Measurement of the morphological neck characteristics in mm on the CT scans available Month 12
Primary Measurement of graft migration Measurement of the graft migration if existing on the CT scans available 6 months before intervention
Primary Measurement of graft migration Measurement of the graft migration if existing on the CT scans available Month 1
Primary Measurement of graft migration Measurement of the graft migration if existing on the CT scans available Month 3
Primary Measurement of graft migration Measurement of the graft migration if existing on the CT scans available Month 6
Primary Measurement of graft migration Measurement of the graft migration if existing on the CT scans available Month 12
Primary Measurement of length between anatomical points evolution Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available. 6 months before intervention
Primary Measurement of length between anatomical points evolution Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available. Month 1
Primary Measurement of length between anatomical points evolution Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available. Month 3
Primary Measurement of length between anatomical points evolution Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available. Month 6
Primary Measurement of length between anatomical points evolution Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available. Month 12
Secondary Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis Month
Secondary Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis 6 months before intervention
Secondary Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis Month 1
Secondary Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis Month 3
Secondary Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis Month 6
Secondary Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis Month 12
Secondary Repeatability between measures (intra observer variability) Descriptive analysis of the different measurements by overlaps metric analysis 6 months before intervention
Secondary Repeatability between measures (intra observer variability) Descriptive analysis of the different measurements by overlaps metric analysis Month 1
Secondary Repeatability between measures (intra observer variability) Descriptive analysis of the different measurements by overlaps metric analysis Month 3
Secondary Repeatability between measures (intra observer variability) Descriptive analysis of the different measurements by overlaps metric analysis Month 6
Secondary Repeatability between measures (intra observer variability) Descriptive analysis of the different measurements by overlaps metric analysis Month 12
Secondary Average time for segmentation (sec) The time for segmentation by junior/senior surgeon and software is recorded 6 months before intervention
Secondary Average time for segmentation (sec) The time for segmentation by junior/senior surgeon and software is recorded Month 1
Secondary Average time for segmentation (sec) The time for segmentation by junior/senior surgeon and software is recorded Month 3
Secondary Average time for segmentation (sec) The time for segmentation by junior/senior surgeon and software is recorded Month 6
Secondary Average time for segmentation (sec) The time for segmentation by junior/senior surgeon and software is recorded Month 12
Secondary Average time for segmentation in comparison with semi-automated segmentation Description of the average time between the different techniques. 6 months before intervention
Secondary Average time for segmentation in comparison with semi-automated segmentation Description of the average time between the different techniques. Month 1
Secondary Average time for segmentation in comparison with semi-automated segmentation Description of the average time between the different techniques. Month 3
Secondary Average time for segmentation in comparison with semi-automated segmentation Description of the average time between the different techniques. Month 6
Secondary Average time for segmentation in comparison with semi-automated segmentation Description of the average time between the different techniques. Month 12
Secondary Total Volume measurement of AAA Description of the volume measurement of the AAA with the following items:
Volume circulating
Intraluminal thrombus volume
Calcification volume
6 months before intervention
Secondary Total Volume measurement of AAA Description of the volume measurement of the AAA with the following items:
Volume circulating
Intraluminal thrombus volume
Calcification volume
Month 1
Secondary Total Volume measurement of AAA Description of the volume measurement of the AAA with the following items:
Volume circulating
Intraluminal thrombus volume
Calcification volume
Month 3
Secondary Total Volume measurement of AAA Description of the volume measurement of the AAA with the following items:
Volume circulating
Intraluminal thrombus volume
Calcification volume
Month 6
Secondary Total Volume measurement of AAA Description of the volume measurement of the AAA with the following items:
Volume circulating
Intraluminal thrombus volume
Calcification volume
Month 12
See also
  Status Clinical Trial Phase
Recruiting NCT05479305 - Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies N/A
Completed NCT03534440 - Assessment of Diastolic Function in High Risk Patients Undergoing Major Vascular Surgery
Completed NCT05247944 - F-BEVAR vs Open Surgery for Complex Abdominal Aortic Aneurysm